Physician profile
Danielle M Dauria
NPI 1710180641
$1,612.46
in general payments reported to CMS, 2019-2025
11 companies · $49.39 in 2025
The $49.39 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $14.39 · 2021: $580 · 2022: $139 · 2023: $467 · 2024: $253 · 2025: $49.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $403.60 | 2021 | |
| Integra Lifesciences Corporation | $297.73 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $199.49 | 2022-2023 | Grafix Pl |
| Kci USA, INC. | $185.61 | 2019-2022 | |
| Abbvie INC. | $175.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Polynovo North America LLC | $167.00 | 2023 | |
| Solventum Corporation | $52.42 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Misonix INC | $52.33 | 2020-2021 | |
| Novo Nordisk INC | $39.73 | 2024-2025 | Wegovy |
| Convatec INC. | $22.73 | 2024 | |
| Hollister Incorporated | $15.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Dauria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.